Gracell Biotechnologies Inc.
Gracell Biotechnologies Inc., a pioneering force in the biopharmaceutical industry, is headquartered in China (CN) and operates extensively across major global markets. Founded in 2017, the company has rapidly established itself as a leader in cell therapy, focusing on innovative treatments for cancer and autoimmune diseases.
Gracell's core offerings include its proprietary FasTCAR™ technology, which enhances the efficacy and safety of CAR-T cell therapies, setting it apart in a competitive landscape. The company has achieved significant milestones, including successful clinical trials that underscore its commitment to advancing healthcare solutions. With a strong market position and a dedication to transformative therapies, Gracell Biotechnologies continues to make strides in the biopharmaceutical sector, aiming to improve patient outcomes worldwide.
+61 vs industry average
Gracell Biotechnologies Inc.’s score of 99 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Gracell Biotechnologies Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Gracell Biotechnologies Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Gracell Biotechnologies Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Gracell Biotechnologies Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from AstraZeneca PLC
Carbon Disclosure Project
Inherited from AstraZeneca PLCThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from AstraZeneca UK LimitedRE 100
Inherited from AstraZeneca PLCClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project